Skip to content
Trial Eligibility
Menu

Prostate Cancer Clinical Trials near New York, NY

149 studies for Prostate Cancer are recruiting at 387 sites within 50 miles of New York, New York, according to ClinicalTrials.gov data processed .

Distances are city-level approximations. See all Prostate Cancer trials in the US or all trials near New York.

Your ZIP is looked up in your browser. We don't receive or store it.

Recruiting now

Prostate Cancer studies enrolling near New York

Showing the 50 nearest of 149 studies.
  1. Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer

    NCT05946213

    • Phase 3
    • Ages 18 years and older
    • Sex: Male

    Nearest sites: Lenox Hill Hospital (New York, NY); Manhattan Eye Ear and Throat Hospital (New York, NY)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    21 sites within 50 mi
  2. Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging

    NCT04423211

    • Phase 3
    • Ages 18 years and older
    • Sex: Male

    Nearest sites: Lenox Hill Hospital (New York, NY); Manhattan Eye Ear and Throat Hospital (New York, NY)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    20 sites within 50 mi
  3. This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.

    NCT07028853

    • Phase 3
    • Ages 18 years and older
    • Sex: Male

    Nearest sites: Evelyn H. Lauder Breast and Imaging Center (BAIC). (New York, NY); Memorial Sloan Kettering Cancer Center - Main Campus (New York, NY)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    14 sites within 50 mi
  4. Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

    NCT05334069

    • Observational
    • Ages 40 to 75 years
    • Sex: All
    • Accepts healthy volunteers

    Nearest sites: NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center (New York, NY); Queens Hospital Center (Jamaica, NY)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    10 sites within 50 mi
  5. Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and Its Effect on Patients With Advanced Prostate Cancer, RECIPROCAL Trial

    NCT07200830

    • Phase 3
    • Ages 18 years and older
    • Sex: Male

    Nearest sites: Memorial Sloan Kettering Cancer Center (New York, NY); Montefiore Medical Center - Moses Campus (The Bronx, NY)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    10 sites within 50 mi
  6. Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

    NCT03866382

    • Phase 2
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Memorial Sloan Kettering Cancer Center (New York, NY); NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center (New York, NY)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    9 sites within 50 mi
  7. Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial

    NCT06931340

    • Phase 3
    • Ages 18 years and older
    • Sex: Male

    Nearest sites: Memorial Sloan Kettering Cancer Center (New York, NY); Mount Sinai Hospital (New York, NY)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    9 sites within 50 mi
  8. A Study of Tinengotinib (TT-00420) in Combination With Standard Treatments in People With Prostate Cancer

    NCT06457919

    • Phase 1/2
    • Ages 18 years and older
    • Sex: Male

    Nearest sites: Columbia University (New York, NY); Memorial Sloan Kettering Cancer Center (New York, NY)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    8 sites within 50 mi
  9. [18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone Pet Imaging in Patients With Progressive Prostate or Salivary Gland Cancer

    NCT00588185

    • Interventional
    • Ages Any age
    • Sex: Male

    Nearest sites: Memorial Sloan Kettering Cancer Center (New York, NY); Memorial Sloan Kettering Nassau (Consent Only) (Uniondale, NY)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    7 sites within 50 mi
  10. A Study of 2141-V11 in Combination With Standard Treatments in People With Prostate Cancer

    NCT06347705

    • Phase 2
    • Ages 18 years and older
    • Sex: Male

    Nearest sites: Memorial Sloan Kettering Cancer Center (All protocol activites) (New York, NY); Memorial Sloan Kettering Nassau (Limited Protocol Activites) (Rockville Centre, NY)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    7 sites within 50 mi
  11. MATCH-UP: MAking Telehealth-Delivery of Cancer Care at Home Effective and Safe-Upscaled: A Pragmatic Cluster Randomized Trial

    NCT06954337

    • Interventional
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Memorial Sloan Kettering Cancer Center (All Protocol Activites) (New York, NY); Memorial Sloan Kettering Nassau (All Protocol Activities) (Uniondale, NY)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    7 sites within 50 mi
  12. A Study of Changes to Prostate Procedures

    NCT06986083

    • Phase 3
    • Ages 18 years and older
    • Sex: Male

    Nearest sites: Memorial Sloan Kettering Cancer Center (All Protocol Activities) (New York, NY); Memorial Sloan Kettering Nassau (Consent Only) (Uniondale, NY)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    7 sites within 50 mi
  13. A Study of Tarlatamab for People With Prostate Cancer

    NCT07111507

    • Phase 2
    • Ages 18 years and older
    • Sex: Male

    Nearest sites: Memorial Sloan Kettering Cancer Center (All Protocol Activities) (New York, NY); Memorial Sloan Kettering Nassau (Limited Protocol Activities) (Uniondale, NY)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    7 sites within 50 mi
  14. Comparing Two Different Boost Approaches in Radiation Therapy for People With Prostate Cancer

    NCT07548164

    • Phase 3
    • Ages Any age
    • Sex: Male

    Nearest sites: Memorial Sloan Kettering Cancer Center (All Protocol Activites) (New York, NY); Memorial Sloan Kettering at Nassau (Limited Protocol Activities) (Uniondale, NY)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    7 sites within 50 mi
  15. A Study of Lower Dose Radiation Therapy for People With Prostate Cancer

    NCT07635238

    • Phase 2
    • Ages 18 years and older
    • Sex: Male

    Nearest sites: Memorial Sloan Kettering Cancer Center (All Protocol Activities) (New York, NY); Memorial Sloan Kettering at Nassau (Limited Protocol Activities) (Uniondale, NY)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    7 sites within 50 mi
  16. A Study of a New PET Scanner in People With Cancer

    NCT07690917

    • Observational
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Memorial Sloan Kettering Cancer Center (New York, NY); Memorial Sloan Kettering Nassau (Consent Only) (Rockville Centre, NY)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    7 sites within 50 mi
  17. Radiation Therapy Approaches for People With Prostate Cancer

    NCT07751159

    • Phase 2
    • Ages Any age
    • Sex: All

    Nearest sites: Memorial Sloan Kettering Cancer Center (All Protocol Activites) (New York, NY); Memorial Sloan Kettering at Nassau (Limited Protocol Activities) (Uniondale, NY)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    7 sites within 50 mi
  18. SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

    NCT03452774

    • Observational
    • Ages Any age
    • Sex: All

    Nearest sites: Massive Bio SYNERGY-AI site (New York, NY); Massive Bio SYNERGY-AI site (Staten Island, NY)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    6 sites within 50 mi
  19. Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer

    NCT03678025

    • Phase 3
    • Ages 18 years and older
    • Sex: Male

    Nearest sites: NYP/Weill Cornell Medical Center (New York, NY); Montefiore Medical Center - Moses Campus (The Bronx, NY)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    6 sites within 50 mi
  20. Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)

    NCT05519449

    • Phase 1
    • Ages 18 to 100 years
    • Sex: Male

    Nearest sites: Memorial Sloan Kettering Cancer Center (New York, NY); NYU Langone Health (New York, NY)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    6 sites within 50 mi
  21. Evaluating the Implementation of a Comprehensive Multilevel Virtual Oncology Program Among Veterans Diagnosed With Lung, Colorectal, Prostate, and Breast Cancers in the US Department of Veterans Affairs

    NCT06559059

    • Interventional
    • Ages 18 years and older
    • Sex: All

    Nearest sites: VA New York Harbor Health Care System - Manhattan (New York, NY); VA New York Harbor Healthcare System - Harlem Community Center (New York, NY)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    5 sites within 50 mi
  22. A Study of Pasritamig With Docetaxel Versus Docetaxel in Participants With Metastatic Castration-Resistant Prostate Cancer

    NCT07225946

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest sites: NYU Langone Health Laura and Isaac Perlmutter Cancer Center (New York, NY); Montefiore Medical Center (The Bronx, NY)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    5 sites within 50 mi
  23. International Registry for Men With Advanced Prostate Cancer (IRONMAN)

    NCT03151629

    • Observational
    • Ages 21 years and older
    • Sex: Male

    Nearest sites: Columbia University Medical Center (New York, NY); Memorial Sloan Kettering Cancer Center (New York, NY)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    4 sites within 50 mi
  24. A Trial to Find Out if REGN5678 (Nezastomig) is Safe and How Well it Works Alone or in Combination With Cemiplimab for Adult Participants With Metastatic Castration-Resistant Prostate Cancer and Other Tumors

    NCT03972657

    • Phase 1/2
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Columbia University - The Trustees of Columbia University in the City of New York (New York, NY); Icahn School of Medicine at Mount Sinai (New York, NY)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    4 sites within 50 mi
  25. Developing New Educational Materials About Genetic Testing for a Diverse Group of Cancer Patients

    NCT04751435

    • Interventional
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Memorial Sloan Kettering at Ralph Lauren Center (Limited Protocol Activities) (New York, NY); Kings County Hopsital Center (Brooklyn, NY)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    4 sites within 50 mi
  26. Clinical Trial of Approaches to Prostate Cancer Surgery

    NCT05155501

    • Interventional
    • Ages 40 to 80 years
    • Sex: Male

    Nearest sites: Memorial Sloan Kettering Cancer Center (New York, NY); Weill Cornell Medicine (New York, NY)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    4 sites within 50 mi
  27. Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors

    NCT05176483

    • Phase 1
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Exelixis Clinical Site #6 (New York, NY); Exelixis Clinical Site #60 (New York, NY)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    4 sites within 50 mi
  28. A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors

    NCT06465069

    • Phase 1
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Columbia University Irving Medical Center (New York, NY); Icahn School of Medicine at Mount Sinai (New York, NY)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    4 sites within 50 mi
  29. Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC

    NCT06855277

    • Phase 3
    • Ages 18 to 100 years
    • Sex: Male

    Nearest sites: Weill Cornell Medicine NY-Presb (New York, NY); Montefiore Medical Center (The Bronx, NY)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    4 sites within 50 mi
  30. Evaluating BL-M14D1 in Subjects With Locally Advanced or Metastatic Small Cell Lung Cancer and Neuroendocrine Tumors

    NCT07080242

    • Phase 1
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Icahn School of Medicine at Mount Sinai (New York, NY); John Theurer Cancer Center-Hackensack (Hackensack, NJ)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    4 sites within 50 mi
  31. A Clinical Study of KTX-2001 in Subjects With Metastatic Castration-Resistant Prostate Cancer (STRIKE-001)

    NCT07103018

    • Phase 1
    • Ages 18 years and older
    • Sex: Male

    Nearest sites: Columbia University Irving Medical Center (New York, NY); Memorial Sloan Kettering Cancer Center (New York, NY)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    4 sites within 50 mi
  32. A Study of Pasritamig With or Without JNJ-87189401 Versus Placebo for Late Line Metastatic Castration-resistant Prostate Cancer (mCRPC)

    NCT07164443

    • Phase 3
    • Ages 18 years and older
    • Sex: Male

    Nearest sites: Columbia University Medical Center (New York, NY); NYU Langone Health Laura and Isaac Perlmutter Cancer Center (New York, NY)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    4 sites within 50 mi
  33. Phase I/II Trial of Pembrolizumab and Androgen-receptor Inhibitor With or Without 225Ac-J591 for Progressive Metastatic Castration Resistant Prostate Cancer

    NCT04946370

    • Phase 1/2
    • Ages 18 years and older
    • Sex: Male

    Nearest sites: Columbia University Irving Cancer Center (New York, NY); New York Presbyterian/Weill Cornell Medical Center (New York, NY)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    3 sites within 50 mi
  34. A Study of Pasritamig (JNJ-78278343) in Combination With Other Agents for Metastatic Prostate Cancer

    NCT05818683

    • Phase 1
    • Ages 18 years and older
    • Sex: Male

    Nearest sites: NYU Langone Health (New York, NY); Perlmutter Cancer Center at NYU Langone Brooklyn (Brooklyn, NY)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    3 sites within 50 mi
  35. Androgen Suppression Combined With Nodal Irradiation and Dose Escalated Prostate Treatment

    NCT06235697

    • Phase 3
    • Ages 18 years and older
    • Sex: Male

    Nearest sites: Lenox Hill Hospital (New York, NY); Manhattan Eye Ear and Throat Hospital (New York, NY)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    3 sites within 50 mi
  36. Study of AZD0754 in Participants With Metastatic Prostate Cancer

    NCT06267729

    • Phase 1/2
    • Ages 18 to 130 years
    • Sex: Male

    Nearest sites: Research Site (New York, NY); Research Site (New York, NY)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    3 sites within 50 mi
  37. A Study of SYNC-T Therapy SV-102 in Participants With Metastatic Castration-Resistant Prostate Cancer

    NCT06533644

    • Phase 2
    • Ages 18 years and older
    • Sex: Male

    Nearest sites: NYU Langone (New York, NY); Weill Cornell (New York, NY)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    3 sites within 50 mi
  38. Study Evaluating Dosimetry, Randomized Dose Optimization, Dose Escalation and Efficacy of Ac-225 Rosopatamab Tetraxetan in Participants With PSMA PET-Positive Castration-Resistant Prostate Cancer (CRPC)

    NCT06549465

    • Phase 2
    • Ages 18 years and older
    • Sex: Male

    Nearest sites: Laura & Isaac Perlmutter Cancer Center (New York, NY); Memorial Sloan Kettering Cancer Center (New York, NY)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    3 sites within 50 mi
  39. Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial

    NCT06632977

    • Phase 2
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Mount Sinai Hospital (New York, NY); Hackensack University Medical Center (Hackensack, NJ)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    3 sites within 50 mi
  40. A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation

    NCT06778863

    • Phase 1
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Memorial Sloan Kettering Cancer Center (New York, NY); NYU Langone Health (New York, NY)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    3 sites within 50 mi
  41. Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted Therapy

    NCT06780670

    • Phase 2/3
    • Ages 18 to 100 years
    • Sex: Male

    Nearest sites: Mount Sinai Hosp Med School (New York, NY); Montefiore Medical Center (The Bronx, NY)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    3 sites within 50 mi
  42. A Study of Metastases Free Survival With Saruparib vs Placebo Added to a Standard RT/ADT in Men With High-risk Prostate Cancer With a BRCA Mutation

    NCT06952803

    • Phase 3
    • Ages 18 years and older
    • Sex: Male

    Nearest sites: Research Site (New York, NY); Research Site (Hackensack, NJ)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    3 sites within 50 mi
  43. Phase I Study of 225Ac-J591 Plus 177Lu-PSMA Small Molecule for Progressive Metastatic Castration Resistant Prostate Cancer

    NCT04886986

    • Phase 1
    • Ages 18 to 99 years
    • Sex: Male

    Nearest sites: Weill Cornell Medicine New York Presbyterian (New York, NY); Brooklyn Methodist Hospital - New York Presbyterian (Brooklyn, NY)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  44. Study of AZD9574 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid Malignancies

    NCT05417594

    • Phase 1/2
    • Ages 18 to 130 years
    • Sex: All

    Nearest sites: Research Site (New York, NY); Research Site (New York, NY)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  45. Abiraterone, Enzalutamide, or Apalutamide in Castrate-sensitive Prostate Cancer.

    NCT05422911

    • Phase 2
    • Ages 18 years and older
    • Sex: Male

    Nearest sites: VA New York Harbor Healthcare System (New York, NY); James J. Peters VA Medical Center (The Bronx, NY)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  46. Two Fraction Prostate SBRT With DIL SIB

    NCT05864196

    • Phase 1
    • Ages 18 years and older
    • Sex: Male

    Nearest sites: NYCyberKnife at Perlmutter Cancer Center (New York, NY); NYU Langone Hospital - Long Island (Mineola, NY)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  47. A Phase 1 Study of XL309 (ISM3091) Alone and in Combination in Participants With Advanced Solid Tumors

    NCT05932862

    • Phase 1
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Exelixis Clinical Site #5 (New York, NY); Exelixis Clinical Site #9 (New Brunswick, NJ)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  48. An Open-label Study Comparing Lutetium (177Lu) Vipivotide Tetraxetan Versus Observation in PSMA Positive OMPC.

    NCT05939414

    • Phase 3
    • Ages 18 to 100 years
    • Sex: Male

    Nearest sites: Memorial Sloan Kettering Cancer Ctr (New York, NY); Montefiore Hospital (The Bronx, NY)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  49. A Study of JNJ-87189401 Combined With JNJ-78278343 for Advanced Prostate Cancer

    NCT06095089

    • Phase 1
    • Ages 18 years and older
    • Sex: Male

    Nearest sites: Herbert Irving Comprehensive Cancer Center Columbia University Medical Center (New York, NY); START New Jersey (East Brunswick, NJ)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  50. A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies

    NCT06395519

    • Phase 1/2
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Laura & Isaac Perlmutter Cancer Center at NYU Langone Health (New York, NY); Memorial Sloan Kettering Cancer Center (New York, NY)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi

FAQ

Common questions

What is a clinical trial?
A clinical trial is a research study in people that tests a medical, surgical or behavioral intervention, such as an investigational drug or device. Observational studies are also listed: they collect information without assigning a treatment. Read how clinical trials work.
Is there compensation for joining a Prostate Cancer clinical trial?
Compensation for time and travel may be available, but it varies by study and some studies offer none. The amount and schedule are reviewed by an ethics board and described in the consent form. See compensation in clinical trials.
How do I check if I'm eligible?
Each study lists age, sex and other inclusion and exclusion criteria on its ClinicalTrials.gov record. Only the study team can confirm eligibility, usually through a screening call or visit. Talk with your own doctor before joining any study.

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.